CRL(NYSE)
May 22 2012 2:43PM
$33.15
-0.70
Market data is delayed by at least 20 min.
login
Investor Relations
Careers
select a country
argentina
belgium
brazil
canada
china
france
germany
great britain
hungary
ireland
italy
japan
spain
united states
by type
agrochemical & animal health product development
antibody production services
avian vaccine services
biopharmaceutical services
clinical support services
consulting services & insourcing solutions
discovery research services
endotoxin & microbial detection
equipment & instrumentation
genetic testing services
genetically engineered models & services
pathology associates
preclinical services
research animal diagnostic services
research animal models
surgical services
by drug development phase
basic research
discovery
safety assessment
clinical trials support
process manufacturing support
by therapeutic/focus area
biosimilars
cardiovascular
central nervous system
endocrine/metabolic
inflammation
oncology
ophthalmology
skeletal disease
vaccines
full listing
preclinical
discovery & imaging
endotoxin & microbial detection
health reports
research animal models & services
infectious agent surveillance & diagnosis
genetic monitoring
infectious agents
species
surgery & induced models
facility operations & management
custom training
webinars
the source
what's new
press releases
in the news
courses & seminars
events
exhibits
charles river at a glance
history
locations
investor relations
careers
benefits
career development
career events
diversity
frequently asked questions
life at charles river
search positions
humane care initiative
best practices
internal awareness
culture of caring
orientation & training
CHARTER program
3Rs
community relations
corporate quality assurance & regulatory affairs
corporate development
Access THE SOURCE
℠
Health Reports
Quote and Submission Forms
2012 LAL Seminars and Workshops
2012 Research Models and Services US Catalog
Upcoming and Archived Webinars
Models of Aging and Cognitive Decline
New FDA Guidance for Biosimilar Development
DTCC Consortium: Creating and Phenotyping Knockout Mouse Mutants
Access MyVIEW
TM
,
the online management tool
designed to support
your ongoing projects
with Charles River.
access
Charles River Partners with Metabolon ...
New Field Sites Expand Agrochemical Serv...
EMD Millipore Partners with Charles Rive...
Expert Metabolic Profiling and Identific...
Introducing Eureka ...
Elemental Analysis by ICP-OES Now Availa...
view all
Research Models and Services
Discovery Research Services
Preclinical Services
Biopharmaceutical Services
Endotoxin and Microbial Detection
drug discovery, drug development Charles River | Accelerating Drug Development. Exactly. Charles River is a global provider of essential research products and services that advance drug discovery and development. Offerings include research animal models, preclinical testing, early-phase clinical trials and full process manufacturing support.
Deploy configuration revision 2.0.10237.20110804.0149